Novo Nordisk Annual Gross sales Leap on Call for for Ozempic and Wegovy
Novo Nordisk, the Danish pharmaceutical corporate in the back of Ozempic and Wegovy, capped off a moderately turbulent 2024, reporting benefit and earnings on Wednesday that very easily beat Wall Boulevard expectancies.